Principal Investigators

    Thera Neuropharma Europe bvba

    Institution

    Thera Neuropharma Europe bvba

    Contact information of lead PI

    Country

    Belgium

    Title of project or programme

    TherALS-1 : Characterisation of novel small molecule regenerative compounds for the treatment of amyotrophic lateral sclerosis

    Source of funding information

    Flanders Innovation & Entrepreneurship

    Total sum awarded (Euro)

    € 1,121,124

    Start date of award

    01/03/2016

    Total duration of award in years

    2.0

    The project/programme is most relevant to:

    Motor neurone diseases

    Keywords

    Research Abstract

    Lay Summary

    Further information available at:

Types: Investments > €500k
Member States: Belgium
Diseases: Motor neurone diseases
Years: 2016
Database Categories: N/A
Database Tags: N/A

Export as PDF